Home
About
FAQ
History (9)
Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial.
Leukocyte-Adhesion Deficiency Syndrome
Development of a highly sensitive enzyme-linked immunosorbent assay (ELISA) through use of poly-protein G-expressing cell-based microplates.
Isoelectric Focusing
Nirmatrelvir Plus Ritonavir for COVID-19: The First Step Is Getting the Name Right.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Nirmatrelvir Plus Ritonavir for COVID-19: The First Step Is Getting the Name Right.
Wisniewski P, Berjohn CM, Maves RC. Nirmatrelvir Plus Ritonavir for COVID-19: The First Step Is Getting the Name Right. Mil Med. 2022 Nov 19.
View in:
PubMed
authors with profiles
Ryan C. Maves MD